We have a vacancy for a Quality Assurance Specialist at our Worcester Field site. Closing Date: 10 August 2016
Associate Professor Mark Hatherill, Director of SATVI, will present a paper at the TB 2016 Conference taking place in Durban from 16 to 17 July 2016.
SATVI has just been awarded a grant to study the adaptive and innate immune responses associated with spontaneous reversion of QuantiFERON In Tube assay (QFT), used to determine if a person is infected with Mycobacterium tuberculosis (M.tb).
The SATVI Field Site laboratory has received verfication of their proficiency in PBMC isolation and Cryopreservation which was assessed by the Immunology Quality Assessment Contract Laboratory (IQA) at the Duke Human Vaccine Institute (HVC.